BeiGene Ltd - ADR
BGNE
Market Cap$16.37B
Close$
$150.03
13.2% downside
Current Fair Value
13.2% downsideOvervalued by 13.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $16.37 Billion |
|---|---|
| Enterprise Value | $14.60 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-7.51 |
| Beta | 1.34 |
| Outstanding Shares | 95,687,713 |
| Avg 30 Day Volume | 200,125 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -20.86 |
|---|---|
| PEG | 74.72 |
| Price to Sales | 6.17 |
| Price to Book Ratio | 4.94 |
| Enterprise Value to Revenue | 5.28 |
| Enterprise Value to EBIT | -13.3 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
ESG Score
No data
About BeiGene Ltd
CEO: John Oyler